Over the years ahead, the term “somatic recombination” may make its way into the lexicon of more lawyers. Why? Because a new, high...

Amazing times for courts, at the SCOTUS level and all other levels, federal and state. “Chief Justice Defends Judicial Independence After...

Various pundits are saying 2019 will include a surge in litigation.  In that vein, it will be interesting to see if adverse financial...

Age of exposure to toxins is receiving increasing attention from researchers. Below, the abstract from an interesting study of arsenic...

Below, an interesting agenda item from the now ongoing PLAC annual meeting: “10:00 am – 10:30 am:  The Trend Toward Monster Verdicts—What...

A new article consolidates information on the use of chapter 11 by Catholic dioceses. The author is a Penn State law professor, Marie...

Now online is the 1/3 fee petition from Hale  v. State Farm. et al., # 3:12- cv-00660, in the U.S. District Court for the Southern...

As the molecular revolution continues, take a look ahead to what trial lawyers will have for exhibits in the future: Watch Mouse Embryos...

Ever focused on science and law issues, Nathan Schactman’s October 3, 2018 post highlights several new articles focused on points of...

The October 3, 2018 post at Drug & Device blog is a must read. It’s a quick, humorous and pithy summary of a true story – a church-based...

Some years back, a few people (including me, in 2010) bucked conventional wisdom and predicted the rise of class actions in Europe. See,...

As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio...

As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio...

A few far sighted liability insurers are paying attention to molecular science as to alleged or actual toxins, often aided by the...

Use of genomic testing continues to increase to seek to explain the reasons for and drivers of cancer. Some aspects of the newest broad...

Campaign contributions – direct and indirect, and transparent or hidden – are frequent topics for charges and counter-charges of bias and...

It’s good to see more lawyers focused on genomics as related to causation in mass tort cases. A group from Goldberg Segalla just wrote...

Some scientific findings provide both opportunities and risks for litigants in mass tort cases. The point is highlighted by a new paper...

Over the years, I’ve had the good fortune to work as a trial lawyer on some very interesting issues in cases at intersections between...

Kudos to the FDA for taking on the task of trying some research on how to warn about drug-related risks. An August 24, 2018 article at...